Role Of Ati Bala (Abutilon Indicum) In Garbha Sthapaka And Garbha Vruddhikara Prabhava With Growth Retarded Symptoms Of Pregnant Women

The present study was conducted to find out the effect of AtiBala (Abutilon indicum) as a single drug for Garbhasthapakaprabhava and Garbhavruddhikaraprabhava in pregnancy in growth retarded symptoms. Sixty pregnant women of a second and third trimester were included and they were divided into two groups. The effect of Ati Bala ‘choorna’ was compared to the choorna combination of Amalaki, Godanthi and Garbhapalarasa (Amalaki group). The role of Ati Bala in maintaining Garbha sthapaka and Garbha vruddhikaraprabhava was more than the combination of Amalaki, Godanthi and Garbhapalarasa, which was statistically significant. REFERANCES 1. 1. Ashtanga Sutrasthan 12-82, 13-3, 15-4, 20-4,5, 5-24 2. Ashtanga Samgraha Sharira Sthan 1-47, 54, 57, 63, 64, 2-3, 6, 23, 24, 56, 85, 3-5, 4-3, 11, 12, 27, 5-9, 10, 11, 12 3. Bhava Prakasha 24-15, 70-71, 72 4. Charaka Samhita Chikithsa 2-30, 46, 8-33, 34, 35, 36, 37, 30-16, 20 5. Charaka Samhita Nidana 1-8, 9, 12 6. Charaka Samhita Sharir 1-19,77, 2-4, 6, 15, 23, , 31, 33, 35, 3-1, 3, 4, 5, 7, 8, 9, 10, 11, 12, 13, 14, 17, 4-4, 5, 6, 7, 11, 12, 16, 18, 21, 26, 29, 30 7. Chopra R.N, Nayar S.L, Chopra I.C. Abutilon (Malvacene) Glossary of Indian Medicinal plants with active principles 1965-1981 Part 1 8. Dhanalaxmi S, Laxmanan K.K, Subramanyan M.S. Pharmacological and Phytochemical studies on two species of Abutilon, Department of Botany, Bharathiar University Tamilnadu 9. Dayani S, Mistry IU , Skandhan KP. Standardization of preparation of choorna with special reference to Ati Bala. Int J Ayurveda Hebal Medicine, 2015(In press). 10. Report on identification of high risk families, mothers and outcome of their offsprings, ICMR Task Force Study, ICMR New Delhi, 1990 11. Tiwari P.V. Ayurveda PrasutiTantraEvamStreeRoga Part 1, ChwakambhaOrientalia Varanasi, 1986 12. Dutta D.C. Text book of Obstetrics New Central Book Agency, Culcutta 3rd edition 1997 13. Hoffman BL, Well woman care In: Hoffman BL Schorge, Schaffer JI, Halvorson LM, Bradshaw KD, Cunningham FG. Williams Gynecology. New York, McGraw Hill Medical 2012. P2 14. Carigo SD et al. Ultrasound predictors of nconatul outcome intrauterine growth restriction PMID 8989476. 15. Charaka Chikithsa /2-30,46/ 8-33,34, 35, 36, 37/ 30-16 16. Charaka Nidana /1-8, 9 ,12 17. Charaka Shariara /1-19,77 / 2-4,16------------ 1,3,4,5,7,8,9,10,11,12,13,14,17,325 /4-41,5,6,7,11,12,16,18,21,26,29----- / 6-23/ 7-17/ 8-4,5,6,7,11,17,20,21,23,24,26,27,28,29,30,32,33,53------ 18. Charaka Sutrasthem /1-26/2 (charaka) /3-3-2,7,8,9,15,17-------------- 7,8,9 /17-14, /20/22/25/26-18/30-26 19. Charaka Vimanastham /5-8,24 /8-12, 95, 98 20. Worked Health Organization WHO were of mother and baby at the health centre Pg no: 109-112, 1992 21. World Health Organization 1994 Pg. 105 22. Craigo SD et al. Ultrasound predictors of national outcome intra uterine growth restriction PMID 8989476 23. Pelg D, Kennedy CM, Hunter SK: Intra uterine growth restriction identification and management Am Fam Physician 58:453-460 .